IH

Irfan Habeeb Ayyan Kuyyan

Active Director Designated Partner DIN 10018655
DIN 10018655 First appointment Sep 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Irfan Habeeb Ayyan Kuyyan

Data last updated:

Irfan Habeeb Ayyan Kuyyan is a Designated Partner at Msiv Disease And Diagnosis Llp (since 2022). The company operates in Healthcare.

DIN 10018655
Primary Designation Designated Partner
Industry Healthcare
First Appointment 02 Sep 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner02 Sep 20222022Active

Board colleagues of Irfan Habeeb Ayyan Kuyyan

Directorship timeline

Open interactive timeline →
Msiv Disease And Diagnosis Llp
Premium access

Shareholding and investment profile for Irfan Habeeb Ayyan Kuyyan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Irfan Habeeb Ayyan Kuyyan

Irfan Habeeb Ayyan Kuyyan currently holds 1 directorship: Msiv Disease And Diagnosis Llp (Designated Partner, since 02 Sep 2022).

Irfan Habeeb Ayyan Kuyyan was first appointed on 02 Sep 2022 as Designated Partner at Msiv Disease And Diagnosis Llp.

The current boards of Irfan Habeeb Ayyan Kuyyan's companies include Kodali Saidalavi (Msiv Disease And Diagnosis Llp), Muringakal Murshid Ansad (Msiv Disease And Diagnosis Llp), Vineesh Nellisseri Ganapathy (Msiv Disease And Diagnosis Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available